Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs4987046
rs4987046
BRCA2
0.700 GeneticVariation UNIPROT

dbSNP: rs56070345
rs56070345
BRCA2
0.700 GeneticVariation UNIPROT

dbSNP: rs587776650
rs587776650
NBN
A 0.700 CausalMutation CLINVAR

dbSNP: rs587781803
rs587781803
BRCA2
A 0.700 CausalMutation CLINVAR

dbSNP: rs63750695
rs63750695
PMS2
C 0.700 CausalMutation CLINVAR

dbSNP: rs778705666
rs778705666
DPH1
0.700 GeneticVariation UNIPROT

dbSNP: rs80187739
rs80187739
BRCA1
0.700 GeneticVariation UNIPROT

dbSNP: rs80356898
rs80356898
BRCA1
A 0.700 CausalMutation CLINVAR

dbSNP: rs80356993
rs80356993
BRCA1
0.700 GeneticVariation UNIPROT

dbSNP: rs80357233
rs80357233
BRCA1
C 0.700 CausalMutation CLINVAR

dbSNP: rs80357438
rs80357438
BRCA1 ; NBR2
T 0.700 CausalMutation CLINVAR

dbSNP: rs80357462
rs80357462
BRCA1
0.700 GeneticVariation UNIPROT

dbSNP: rs80357474
rs80357474
BRCA1
0.700 GeneticVariation UNIPROT

dbSNP: rs80357669
rs80357669
BRCA1
T 0.700 CausalMutation CLINVAR

dbSNP: rs80357828
rs80357828
BRCA1
G 0.700 CausalMutation CLINVAR

dbSNP: rs80358479
rs80358479
BRCA2
0.700 GeneticVariation UNIPROT

dbSNP: rs80358981
rs80358981
BRCA2
T 0.700 CausalMutation CLINVAR

dbSNP: rs80359078
rs80359078
BRCA2
0.700 GeneticVariation UNIPROT

dbSNP: rs80359176
rs80359176
BRCA2
0.700 GeneticVariation UNIPROT

dbSNP: rs80359477
rs80359477
BRCA2
G 0.700 CausalMutation CLINVAR

dbSNP: rs869312756
rs869312756
ATM
T 0.700 GeneticVariation CLINVAR

dbSNP: rs869312774
rs869312774
PALB2
C 0.700 CausalMutation CLINVAR

dbSNP: rs1695
rs1695
GSTP1
0.030 GeneticVariation BEFREE <i>GSTP1</i> rs1695 is associated with both hematological toxicity and prognosis of ovarian cancer treated with paclitaxel plus carboplatin combination chemotherapy: a comprehensive analysis using targeted resequencing of 100 pharmacogenes. 30038720

2018
dbSNP: rs2070074
rs2070074
GALT
0.050 GeneticVariation BEFREE The difference was most evident for endometrioid and clear cell types of ovarian cancer, in which 3.9% of cases were found to be homozygous for N314D compared with 0.4% of controls, yielding an odds ratio and 95% confidence interval of 14.17 (2.62-76.60). 10667469

2000
dbSNP: rs1048943
rs1048943
CYP1A1
0.020 GeneticVariation BEFREE Ile462Val status seems to represent a meaningful risk factor for ovarian cancer in Caucasians. 22733497

2012